Manulife (Manufacturers Life Insurance)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $173M | Sell |
1,242,331
-518,517
| -29% | -$72.6M | 0.15% | 145 |
|
|
2025
Q4 | $216M | Sell |
1,760,848
-300,056
| -15% | -$36.5M | 0.18% | 118 |
|
|
2025
Q3 | $229M | Sell |
2,060,904
-563,028
| -21% | -$64M | 0.19% | 113 |
|
|
2025
Q2 | $291M | Sell |
2,623,932
-95,568
| -4% | -$10.2M | 0.26% | 86 |
|
|
2025
Q1 | $305M | Sell |
2,719,500
-3,589,218
| -57% | -$370M | 0.29% | 81 |
|
|
2024
Q4 | $583M | Sell |
6,308,718
-33,693
| -0.5% | -$3.03M | 0.51% | 38 |
|
|
2024
Q3 | $532M | Sell |
6,342,411
-260,875
| -4% | -$19.9M | 0.47% | 43 |
|
|
2024
Q2 | $453M | Sell |
6,603,286
-529,237
| -7% | -$35.3M | 0.42% | 46 |
|
|
2024
Q1 | $522M | Sell |
7,132,523
-499,477
| -7% | -$38.4M | 0.48% | 44 |
|
|
2023
Q4 | $618M | Buy |
7,632,000
+3,362,505
| +79% | +$262M | 0.37% | 49 |
|
|
2023
Q3 | $320M | Buy |
4,269,495
+80,605
| +2% | +$6.2M | 0.19% | 89 |
|
|
2023
Q2 | $323M | Buy |
4,188,890
+56,363
| +1% | +$4.5M | 0.18% | 91 |
|
|
2023
Q1 | $343M | Buy |
4,132,527
+30,438
| +0.7% | +$2.52M | 0.19% | 91 |
|
|
2022
Q4 | $352M | Buy |
4,102,089
+944,211
| +30% | +$74.8M | 0.22% | 78 |
|
|
2022
Q3 | $195M | Buy |
3,157,878
+2,161
| +0.1% | +$136K | 0.14% | 123 |
|
|
2022
Q2 | $195M | Buy |
3,155,717
+16,206
| +0.5% | +$1M | 0.14% | 128 |
|
|
2022
Q1 | $187M | Buy |
3,139,511
+22,543
| +0.7% | +$1.44M | 0.12% | 142 |
|
|
2021
Q4 | $227K | Sell |
3,116,968
-758,639
| -20% | -$52.3M | 0.14% | 127 |
|
|
2021
Q3 | $271M | Sell |
3,875,607
-22,105
| -0.6% | -$1.55M | 0.22% | 104 |
|
|
2021
Q2 | $268M | Buy |
3,897,712
+41,104
| +1% | +$2.74M | 0.22% | 107 |
|
|
2021
Q1 | $249M | Sell |
3,856,608
-252,862
| -6% | -$16.3M | 0.22% | 105 |
|
|
2020
Q4 | $239M | Buy |
4,109,470
+45,529
| +1% | +$2.75M | 0.22% | 104 |
|
|
2020
Q3 | $257M | Buy |
4,063,941
+184,213
| +5% | +$12.8M | 0.26% | 86 |
|
|
2020
Q2 | $289M | Sell |
3,879,728
-565,584
| -13% | -$43.3M | 0.27% | 81 |
|
|
2020
Q1 | $332M | Buy |
4,445,312
+973,140
| +28% | +$67.2M | 0.37% | 58 |
|
|
2019
Q4 | $226M | Sell |
3,472,172
-108,353
| -3% | -$7.06M | 0.24% | 105 |
|
|
2019
Q3 | $225M | Sell |
3,580,525
-53,571
| -1% | -$3.5M | 0.25% | 104 |
|
|
2019
Q2 | $246M | Sell |
3,634,096
-680,881
| -16% | -$44.8M | 0.29% | 94 |
|
|
2019
Q1 | $281M | Buy |
4,314,977
+34,139
| +0.8% | +$2.27M | 0.3% | 87 |
|
|
2018
Q4 | $268M | Sell |
4,280,838
-209,530
| -5% | -$14.6M | 0.34% | 79 |
|
|
2018
Q3 | $347M | Sell |
4,490,368
-335,416
| -7% | -$25.3M | 0.37% | 64 |
|
|
2018
Q2 | $342M | Sell |
4,825,784
-229,678
| -5% | -$16.2M | 0.37% | 60 |
|
|
2018
Q1 | $381M | Sell |
5,055,462
-326,632
| -6% | -$26M | 0.42% | 51 |
|
|
2017
Q4 | $386M | Sell |
5,382,094
-60,204
| -1% | -$4.57M | 0.42% | 53 |
|
|
2017
Q3 | $441M | Sell |
5,442,298
-749,324
| -12% | -$57.3M | 0.53% | 39 |
|
|
2017
Q2 | $438M | Buy |
6,191,622
+2,062,886
| +50% | +$137M | 0.53% | 35 |
|
|
2017
Q1 | $280M | Buy |
4,128,736
+778,483
| +23% | +$54.7M | 0.36% | 70 |
|
|
2016
Q4 | $240M | Sell |
3,350,253
-82,350
| -2% | -$6.12M | 0.34% | 75 |
|
|
2016
Q3 | $272M | Buy |
3,432,603
+910,325
| +36% | +$73.9M | 0.4% | 63 |
|
|
2016
Q2 | $210M | Buy |
2,522,278
+251,811
| +11% | +$22.3M | 0.32% | 76 |
|
|
2016
Q1 | $209M | Sell |
2,270,467
-683,349
| -23% | -$61.6M | 0.18% | 92 |
|
|
2015
Q4 | $299K | Buy |
2,953,816
+143,801
| +5% | +$15M | 0.28% | 64 |
|
|
2015
Q3 | $276K | Buy |
2,810,015
+95,683
| +4% | +$10.6M | 0.29% | 71 |
|
|
2015
Q2 | $318K | Buy |
2,714,332
+179,796
| +7% | +$19.6M | 0.38% | 54 |
|
|
2015
Q1 | $249K | Buy |
2,534,536
+36,991
| +1% | +$3.76M | 0.32% | 63 |
|
|
2014
Q4 | $235K | Buy |
2,497,545
+552,522
| +28% | +$57.1M | 0.34% | 64 |
|
|
2014
Q3 | $207K | Buy |
1,945,023
+295,605
| +18% | +$28.9M | 0.31% | 64 |
|
|
2014
Q2 | $137M | Sell |
1,649,418
-423,943
| -20% | -$33M | 0.21% | 97 |
|
|
2014
Q1 | $147K | Buy |
2,073,361
+91,451
| +5% | +$7.17M | 0.23% | 93 |
|
|
2013
Q4 | $149K | Sell |
1,981,910
-142,670
| -7% | -$9.93M | 0.23% | 77 |
|
|
2013
Q3 | $134K | Buy |
2,124,580
+23,867
| +1% | +$1.43M | 0.22% | 74 |
|
|
2013
Q2 | $108M | Buy |
+2,100,713
| New | +$109M | 0.2% | 96 |
|
Other funds holding GILD
VCM
VPM
Manulife (Manufacturers Life Insurance)'s GILD Position: Q1 2026 in Review
Manulife (Manufacturers Life Insurance) reduced its Gilead Sciences (GILD) stake by 29% in Q1 2026, selling an estimated $72.6M and leaving 1,242,331 shares worth $173M. The position accounts for 0.15% of the portfolio, ranked #145.
Manulife (Manufacturers Life Insurance) first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $618M in Q4 2023. 2,315 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Manulife (Manufacturers Life Insurance) held 1,242,331 shares of Gilead Sciences worth $173M as of Q1 2026.
- Manulife (Manufacturers Life Insurance) sold 518,517 Gilead Sciences shares in Q1 2026, an estimated $72.6M.
- Gilead Sciences made up 0.15% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #145 holding.
- Manulife (Manufacturers Life Insurance) first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Manulife (Manufacturers Life Insurance)'s Gilead Sciences position peaked at $618M in Q4 2023.
- 2,315 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.